Jensen, A., Uhl, M., Chaudhri, N. S., Federspil, P. A., Freier, K., Krauß, J., & Debus, J. (2016). Carbon ion therapy (C12) for high-grade malignant salivary gland tumors (MSGTs) of the head and neck: Do non-ACCs profit from dose escalation? Radiation oncology, 11, . https://doi.org/10.1186/s13014-016-0657-z
Chicago-Zitierstil (17. Ausg.)Jensen, Alexandra, Matthias Uhl, Naved Sarwar Chaudhri, Philippe A. Federspil, Kolja Freier, Jürgen Krauß, und Jürgen Debus. "Carbon Ion Therapy (C12) for High-grade Malignant Salivary Gland Tumors (MSGTs) of the Head and Neck: Do Non-ACCs Profit from Dose Escalation?" Radiation Oncology 11 (2016). https://doi.org/10.1186/s13014-016-0657-z.
MLA-Zitierstil (9. Ausg.)Jensen, Alexandra, et al. "Carbon Ion Therapy (C12) for High-grade Malignant Salivary Gland Tumors (MSGTs) of the Head and Neck: Do Non-ACCs Profit from Dose Escalation?" Radiation Oncology, vol. 11, 2016, https://doi.org/10.1186/s13014-016-0657-z.